Cyclosporine: Difference between revisions

(administration edits)
(adult dosing)
Line 6: Line 6:


==Adult Dosing==
==Adult Dosing==
===Organ transplant rejection prophylaxis===
* Dosing protocols vary
* Start: 7-9 mg/kg/day PO divided BID; give 1st dose 4-12 hr pre-transplant or postop
* For heart, kidney, or liver transplant, adjust dose based on target levels, rejection status, adverse effects
===Rheumatoid arthritis, severe===
* Start: 2.5 mg/kg/day PO divided BID, increase 0.5-0.75 mg/kg/day after 8 wk and after 12 wk; Max: 4 mg/kg/day
* Use alone or with methotrexate; decreased 25-50% PRN adverse effects, discontinue if no benefit by 16 wks
===Psoriasis, severe recalcitrant plaque===
* Start: 2.5 mg/kg/day PO divided BID, increase 0.5 mg/kg/day q 2 wk after 4 wk; Max: 4 mg/kg/day
* Decrease 25-50% PRN adverse effects, discontinue if inadequate response after 6 weeks on max tolerated dose


==Pediatric Dosing==
==Pediatric Dosing==

Revision as of 01:37, 9 February 2016

Administration

  • Type: immunosuppressant
  • Dosage Forms: 25,100; 100/mL
  • Routes of Administration: PO, injection
  • Common Trade Names: Sandimmune

Adult Dosing

Organ transplant rejection prophylaxis

  • Dosing protocols vary
  • Start: 7-9 mg/kg/day PO divided BID; give 1st dose 4-12 hr pre-transplant or postop
  • For heart, kidney, or liver transplant, adjust dose based on target levels, rejection status, adverse effects

Rheumatoid arthritis, severe

  • Start: 2.5 mg/kg/day PO divided BID, increase 0.5-0.75 mg/kg/day after 8 wk and after 12 wk; Max: 4 mg/kg/day
  • Use alone or with methotrexate; decreased 25-50% PRN adverse effects, discontinue if no benefit by 16 wks

Psoriasis, severe recalcitrant plaque

  • Start: 2.5 mg/kg/day PO divided BID, increase 0.5 mg/kg/day q 2 wk after 4 wk; Max: 4 mg/kg/day
  • Decrease 25-50% PRN adverse effects, discontinue if inadequate response after 6 weeks on max tolerated dose

Pediatric Dosing

Special Populations

Renal Dosing

  • Adult:
  • Pediatric:

Hepatic Dosing

  • Adult:
  • Pediatric:

Contraindications

  • Allergy to class/drug

Adverse Reactions

Serious

Common

Pharmacology

  • Half-life:
  • Metabolism:
  • Excretion:

Mechanism of Action

Comments

See Also

References